MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 529813 | Name: Pyruvate sodium
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sodium pyruvate is an antioxidant potentially for the treatment of chronic obstructive pulmonary disease.

Chemical Structure

Pyruvate sodium
Pyruvate sodium
CAS#113-24-6 (Sodium)

Theoretical Analysis

MedKoo Cat#: 529813

Name: Pyruvate sodium

CAS#: 113-24-6 (Sodium)

Chemical Formula: C3H3NaO3

Exact Mass: 0.0000

Molecular Weight: 110.04

Elemental Analysis: C, 32.74; H, 2.75; Na, 20.89; O, 43.62

Price and Availability

Size Price Availability Quantity
10g USD 150.00 Ready to ship
25g USD 250.00 2 weeks
50g USD 400.00 2 weeks
100g USD 650.00 2 weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
113-24-6 (Sodium) 127-17-3 (free acid)
Synonym
FP-0019; FP-0020; RES-001; RES-100; RES-110; FP0019; FP0020; RES001; RES100; RES110; FP 0019; FP 0020; RES 001; RES 100; RES 110
IUPAC/Chemical Name
sodium 2-oxopropanoate
InChi Key
DAEPDZWVDSPTHF-UHFFFAOYSA-M
InChi Code
InChI=1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1
SMILES Code
CC(C([O-])=O)=O.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Product Data
Certificate of Analysis
View CoA: current batch, Lot#T7C12I04
Safety Data Sheet (SDS)
View Safety Data Sheet (SDS)
Instruction
View handling instruction
Biological target:
Pyruvate sodium is a free radical scavenger and has been shown to protect against hydrogen peroxide mediated apoptosis.
In vitro activity:
Pyruvate may be a potential treatment option for diabetic nephropathy. This study investigated the effects of pyruvate on high glucose-induced ER stress and apoptosis in HK-2 cells. Their results suggest that pyruvate treatment ameliorated the effects of high glucose, which can induce ROS production, apoptosis and ER stress in HK-2 cells. Reference: FEBS Open Bio. 2020 May; 10(5): 827–834. https://pubmed.ncbi.nlm.nih.gov/31598701/
In vivo activity:
This study found that pyruvate inhibited the proliferation of various types of cancer cells. Pyruvate administration reduced histone expression and inhibited tumor growth in xenograft mice without significant side effects. Intracellular pyruvate concentrations inversely correlate with histone protein levels in tissues from cervical and lung cancer patients. Reference: Nucleic Acids Res. 2019 Dec 2; 47(21): 11132–11150. https://pubmed.ncbi.nlm.nih.gov/32150786/
Solvent mg/mL mM
Solubility
Water 100.0 908.80
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 110.04 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Zhang XM, Wang YZ, Tong JD, Ning XC, Zhou FQ, Yang XH, Jin HM. Pyruvate alleviates high glucose-induced endoplasmic reticulum stress and apoptosis in HK-2 cells. FEBS Open Bio. 2020 May;10(5):827-834. doi: 10.1002/2211-5463.12834. Epub 2020 Apr 10. PMID: 32150786; PMCID: PMC7193158. 2. Tornin J, Mateu-Sanz M, Rodríguez A, Labay C, Rodríguez R, Canal C. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma. Sci Rep. 2019 Jul 23;9(1):10681. doi: 10.1038/s41598-019-47128-1. PMID: 31337843; PMCID: PMC6650457. 3. Ma R, Wu Y, Zhai Y, Hu B, Ma W, Yang W, Yu Q, Chen Z, Workman JL, Yu X, Li S. Exogenous pyruvate represses histone gene expression and inhibits cancer cell proliferation via the NAMPT-NAD+-SIRT1 pathway. Nucleic Acids Res. 2019 Dec 2;47(21):11132-11150. doi: 10.1093/nar/gkz864. PMID: 31598701; PMCID: PMC6868375. 4. Saito K, Matsumoto S, Devasahayam N, Subramanian S, Munasinghe JP, Morris HD, Lizak MJ, Ardenkjaer-Larsen JH, Mitchell JB, Krishna MC. Transient decrease in tumor oxygenation after intravenous administration of pyruvate. Magn Reson Med. 2012 Mar;67(3):801-7. doi: 10.1002/mrm.23065. Epub 2011 Oct 17. PMID: 22006570; PMCID: PMC3262125.
In vitro protocol:
1. Zhang XM, Wang YZ, Tong JD, Ning XC, Zhou FQ, Yang XH, Jin HM. Pyruvate alleviates high glucose-induced endoplasmic reticulum stress and apoptosis in HK-2 cells. FEBS Open Bio. 2020 May;10(5):827-834. doi: 10.1002/2211-5463.12834. Epub 2020 Apr 10. PMID: 32150786; PMCID: PMC7193158. 2. Tornin J, Mateu-Sanz M, Rodríguez A, Labay C, Rodríguez R, Canal C. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma. Sci Rep. 2019 Jul 23;9(1):10681. doi: 10.1038/s41598-019-47128-1. PMID: 31337843; PMCID: PMC6650457.
In vivo protocol:
1. Ma R, Wu Y, Zhai Y, Hu B, Ma W, Yang W, Yu Q, Chen Z, Workman JL, Yu X, Li S. Exogenous pyruvate represses histone gene expression and inhibits cancer cell proliferation via the NAMPT-NAD+-SIRT1 pathway. Nucleic Acids Res. 2019 Dec 2;47(21):11132-11150. doi: 10.1093/nar/gkz864. PMID: 31598701; PMCID: PMC6868375. 2. Saito K, Matsumoto S, Devasahayam N, Subramanian S, Munasinghe JP, Morris HD, Lizak MJ, Ardenkjaer-Larsen JH, Mitchell JB, Krishna MC. Transient decrease in tumor oxygenation after intravenous administration of pyruvate. Magn Reson Med. 2012 Mar;67(3):801-7. doi: 10.1002/mrm.23065. Epub 2011 Oct 17. PMID: 22006570; PMCID: PMC3262125.
1: Kładna A, Marchlewicz M, Piechowska T, Kruk I, Aboul-Enein HY. Reactivity of pyruvic acid and its derivatives towards reactive oxygen species. Luminescence. 2015 Nov;30(7):1153-8. doi: 10.1002/bio.2879. PubMed PMID: 25754627. 2: Phillips B, Esposito M, Verbeeck J, Boué S, Iskandar A, Vuillaume G, Leroy P, Krishnan S, Kogel U, Utan A, Schlage WK, Bera M, Veljkovic E, Hoeng J, Peitsch MC, Vanscheeuwijck P. Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology. Inhal Toxicol. 2015;27(9):405-31. doi: 10.3109/08958378.2015.1046000. PubMed PMID: 26295358. 3: Jardine KJ, Sommer ED, Saleska SR, Huxman TE, Harley PC, Abrell L. Gas phase measurements of pyruvic acid and its volatile metabolites. Environ Sci Technol. 2010 Apr 1;44(7):2454-60. doi: 10.1021/es903544p. PubMed PMID: 20210357. 4: Al-Gayyar MM, Alyoussef A, Hamdan AM, Abbas A, Darweish MM, El-Hawwary AA. Cod liver oil ameliorates sodium nitrite-induced insulin resistance and degradation of rat hepatic glycogen through inhibition of cAMP/PKA pathway. Life Sci. 2015 Jan 1;120:13-21. doi: 10.1016/j.lfs.2014.11.002. PubMed PMID: 25447450. 5: Olek RA, Kujach S, Wnuk D, Laskowski R. Single sodium pyruvate ingestion modifies blood acid-base status and post-exercise lactate concentration in humans. Nutrients. 2014 May 16;6(5):1981-92. doi: 10.3390/nu6051981. PubMed PMID: 24841105; PubMed Central PMCID: PMC4042581. 6: Yang J, Zhao JX, Wang Y, Chen G, Cheng WN, Luo X, Pei XT, Zhao L, Su Q, Zhou H. Effects of sodium pyruvate on ameliorating metabolic acidosis. Artif Cells Nanomed Biotechnol. 2016;44(1):48-55. doi: 10.3109/21691401.2014.901335. PubMed PMID: 24697727. 7: Hu S, Liu WW, Zhao Y, Lin ZL, Luo HM, Bai XD, Sheng ZY, Zhou FQ. Pyruvate-enriched oral rehydration solution improved intestinal absorption of water and sodium during enteral resuscitation in burns. Burns. 2014 Jun;40(4):693-701. doi: 10.1016/j.burns.2013.09.030. PubMed PMID: 24280524. 8: Furumoto T, Yamaguchi T, Ohshima-Ichie Y, Nakamura M, Tsuchida-Iwata Y, Shimamura M, Ohnishi J, Hata S, Gowik U, Westhoff P, Bräutigam A, Weber AP, Izui K. A plastidial sodium-dependent pyruvate transporter. Nature. 2011 Aug 24;476(7361):472-5. doi: 10.1038/nature10250. Erratum in: Nature. 2011 Oct 13;478(7368):274. PubMed PMID: 21866161. 9: Sharma P, Mongan PD. Hypertonic sodium pyruvate solution is more effective than Ringer's ethyl pyruvate in the treatment of hemorrhagic shock. Shock. 2010 May;33(5):532-40. doi: 10.1097/SHK.0b013e3181cc02b3. PubMed PMID: 19953008. 10: El Sayed SM, El-Magd RM, Shishido Y, Chung SP, Diem TH, Sakai T, Watanabe H, Kagami S, Fukui K. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects. J Bioenerg Biomembr. 2012 Feb;44(1):61-79. doi: 10.1007/s10863-012-9409-4. PubMed PMID: 22318356. 11: Petrat F, Rönn T, de Groot H. Protection by pyruvate infusion in a rat model of severe intestinal ischemia-reperfusion injury. J Surg Res. 2011 May 15;167(2):e93-e101. doi: 10.1016/j.jss.2009.12.005. PubMed PMID: 20371088. 12: Ma CQ, Li JC, Qiu JH, Wang M, Xu P. Recovery of pyruvic acid from biotransformation solutions. Appl Microbiol Biotechnol. 2006 Apr;70(3):308-14. PubMed PMID: 16041574. 13: Ungureanu M, Diculencu D, Archip C. Synthesis and antituberculosis action of some new pyruvic acid derivatives. Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):860-4. PubMed PMID: 20201282. 14: Mazzio E, Soliman KF. Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci Lett. 2003 Feb 6;337(2):77-80. PubMed PMID: 12527392. 15: Cherry BH, Nguyen AQ, Hollrah RA, Williams AG Jr, Hoxha B, Olivencia-Yurvati AH, Mallet RT. Pyruvate stabilizes electrocardiographic and hemodynamic function in pigs recovering from cardiac arrest. Exp Biol Med (Maywood). 2015 Dec;240(12):1774-84. doi: 10.1177/1535370215590821. PubMed PMID: 26088865; PubMed Central PMCID: PMC4935353. 16: Farah IO, Lewis VL, Ayensu WK, Cameron JA. Assessing the survival of MRC5 and a549 cell lines upon exposure to pyruvic Acid, sodium citrate and sodium bicarbonate - biomed 2013. Biomed Sci Instrum. 2013;49:109-16. PubMed PMID: 23686189. 17: Wang X, Hu X, Yang Y, Takata T, Sakurai T. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease. Exp Neurol. 2015 Sep;271:145-54. doi: 10.1016/j.expneurol.2015.06.008. PubMed PMID: 26057947. 18: Kuka J, Makrecka M, Grinberga S, Pugovics O, Liepinsh E, Dambrova M. A short-term high-dose administration of sodium pivalate impairs pyruvate metabolism without affecting cardiac function. Cardiovasc Toxicol. 2012 Dec;12(4):298-303. doi: 10.1007/s12012-012-9169-8. PubMed PMID: 22539084. 19: Fujii T, Nozaki F, Saito K, Hayashi A, Nishigaki Y, Murayama K, Tanaka M, Koga Y, Hiejima I, Kumada T. Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study. Mol Genet Metab. 2014 Jun;112(2):133-8. doi: 10.1016/j.ymgme.2014.04.008. PubMed PMID: 24830361. 20: Asmus C, Mozziconacci O, Schöneich C. Low-temperature NMR characterization of reaction of sodium pyruvate with hydrogen peroxide. J Phys Chem A. 2015 Feb 12;119(6):966-77. doi: 10.1021/jp511831b. PubMed PMID: 25587753; PubMed Central PMCID: PMC4782753.